Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the ...

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the ...

Biologics manufacturing is entering a new phase where agility and proximity matter as much as scale. For decades, the industry relied on the philosophy that “bigger is better,” constructing massive, ...

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the action with an emphasis on biologic drugs. First, active pharmaceutical ...

Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of ...

Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to invest in the U.S. as tariffs targeting the industry loom. The facility’s ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...

FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

Lowering the prices of prescription drugs has been high on United States President Donald Trump’s agenda since he took office in January. He has taken a number of steps, including striking deals with ...